Replies to post #19853 on BioSante Pharmaceuticals, Inc. (BPAX)

[nutsyprofessor]

Beandog you are confused; they always targeted the 1stQ 2013 for the new SPA. What was and still is targeted for the 4thQ 2012 is the final (topline) safety data analysis i.e. the data that Biosante could use for an NDA filing.